|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||68.98 - 70.86|
|52 Week Range||55.80 - 73.42|
|PE Ratio (TTM)||11.33|
|Forward Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Shares of Barnes and Noble are plummeting after a disappointing earnings report showing a bigger than expected loss. We know there have been takeover rumors for Barnes and Noble recently — maybe even taking the company private. What are the odds of this now? Yahoo Finance's Alexis Christoforous and Jared Blikre discuss.
Shares of Kroger are soaring after a strong earnings report. What's in store for the grocer retailer heading into the holidays? Yahoo Finance's Alexis Christoforous and Jared Blikre discuss.
Tim Wentworth, Express Scripts CEO and president, talks to CNBC's Meg Tirrell about the future of the pharmacy benefits manager model, the threat Amazon would bring to the marketplace and consolidation in the industry.
Express Scripts offered profit guidance that outstripped Wall Street estimates, as Amazon and CVS Health-Aetna threaten to shake up the drug sector.
Amid industry consolidation like CVS Health's purchase of Aetna, Express Scripts said it will look into more acquisitions on top of its purchase of medical management firm eviCore.
Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare. In ...
Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare. The ...
Express Scripts Holding Company (NASDAQ:ESRX) outperformed the Healthcare Services industry on the basis of its ROE – producing a higher 23.09% relative to the peer average of 11.05% over theRead More...
UnitedHealth Group Inc (NYSE:UNH), the dominant player in the U.S. health insurance market, has agreed to buy the medical clinic business of Davita Inc (NYSE:DVA) for $4.9 billion, accelerating consolidation in the healthcare space. This could mean good things for UNH stock. In describing the pending merger of CVS Health Corp (NYSE:CVS) and Aetna Inc (NYSE:AET), health insurers are looking to buy facilities and drug dispensing units so they can gain control over costs.
Recent developments in the healthcare space, including the proposed merger between CVS Health Corp (NYSE: CVS ) and Aetna Inc (NYSE: AET ), bodes well for Express Scripts Holding Company (NASDAQ: ESRX ...
Standalone pharmacy-benefit managers negotiate drug prices and have long been a feature of America’s health care system. But that may not be true for much longer.
Announcement: Moody's: CVS/Aetna merger would have negative implications for other health care companies. Global Credit Research- 04 Dec 2017. New York, December 04, 2017-- A merger between CVS Health ...
CVS Health Corp.’s deal to buy insurer Aetna Inc. for about $67.5 billion could be just the start of a new wave of health-care takeovers.
Sears reported a smaller loss, but same-store sales continue to crash. Costco's same-store sales surged, while Express was hopeful about the holiday quarter.
Shares of pharmacy benefit manager Express Scripts (ESRX) are up about 4% since last week, as the company reiterated its desire to adapt to healthcare industry upheavals. On CNBC this morning, the PBM’s chief executive Tim Wentworth said he’d be happy to partner with a health insurer or with Amazon.com (AMZN), if that e-commerce giant jumped into the pharmacy business. As Barron’s reported last year in a cover story (“Pharmacy-Benefit Managers Under Pressure,” July 23, 2016), PBMs like Express Scripts and the Caremark unit of CVS Health (CVS) have faced growing doubt of their claim that they restrain rising drug prices on behalf of the health plan sponsors that hire them.
Express Scripts Holding Co.’s chief executive said he’s open to a deal with a health insurer or partnering with Amazon.com Inc.
Express Scripts, the biggest PBM in the United States, and drug distributors have been under pressure by the speculated entry of Amazon into the prescription drug market. "What (Amazon) will see is the magic isn't in lower net prices to consumers," CEO Tim Wentworth said. Last month, Express Scripts said it would "stand well" against any possible competition from Amazon in the pharmacy benefit management business, but added that the company would be a "natural collaborator" for the ecommerce giant.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Express Scripts Holding chief executive officer said on Thursday on CNBC that he sees Amazon Inc, which has been reported to be interested in entering the pharmacy market, as a possible partner for the ...